Allovir, Inc. (ALVR) Deferred Tax Assets, Valuation Allowance USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Allovir, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2019 to 2023.
  • Allovir, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $181 M, a 120% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $181 M +$98.7 M +120% Dec 31, 2023 10-K 2024-03-15
Q4 2022 $82.2 M +$35.4 M +75.6% Dec 31, 2022 10-K 2024-03-15
Q4 2021 $46.8 M +$22.3 M +90.7% Dec 31, 2021 10-K 2023-02-15
Q4 2020 $24.6 M +$17.8 M +261% Dec 31, 2020 10-K 2022-02-10
Q4 2019 $6.8 M Dec 31, 2019 10-K 2021-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.